Editorial Board disclosures

Chief Editor

Esther Barreiro has no potential conflicts of interest to disclose.

Deputy Chief Editor

Woo-Jung Song has received a grant from AstraZeneca.

Editorial Board

Stefan Andreas has received a grant from ResMed for participation in the SERVE-HF trial, grants from AstraZeneca and GSK for investigator-initiated studies, and honoraria from
AstraZeneca, Boehringer Ingelheim, Novartis, GSK, Roche and Pfizer.

Bruno Archiza has no potential conflicts of interest to disclose.

Danilo C. Berton has received travel grants for participation in scientific events from Boehringer Ingelheim and Chiesi.

James D. Chalmers has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Novartis and Insmed; and received consultancy or speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Insmed, Janssen, Novartis and Zambon.

Sandra Chuang has no potential conflicts of interest to disclose.

Giorgio Ciprani is an advisor to DMG Italy, Dompé Farmaceutici, Opis, Sakura, Stallergenes Greer and Valeas.

Felix J.F. Herth has received personal fees for lecturing and service on advisory boards from Olympus, Uptake, BTG, Lilly, Grifols, Novartis, Astra Zeneca, TEVA, mundipharma,
Boehringer Ingelheim, Boston Scientific, Broncus and medupdate.

Terence Ho Fisher and Paykel has provided Terence Ho and his co-investigator funds for an investigator-initiated study, where the funds are purely used to pay for research-related imaging studies.

James Hull is a Medical Advisory Board member for Bellus Health and has received consultancy fees from MSD Pharmaceuticals.

David Jiménez has served as an advisor or consultant for Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Leo Pharma, Pfizer, ROVI and Sanofi; served as a speaker or a member of a speakers’ bureau for Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Leo Pharma, ROVI and Sanofi; and received grants for clinical research from Daiichi Sankyo, Sanofi and ROVI.

Or Kalchiem-Dekel is a member of the American Association of Bronchology and Interventional Pulmonology 2022 International Conference Scientific Program Committee.

Ahmad Kantar is a member of the American Association of Bronchology and Interventional Pulmonology 2022 International Conference Scientific Program Committee.

Jon R. Konradsen has received has received nonfinancial support from Thermo Fisher Scientific and Meda, and speaker fees from Novartis.

Nakwon Kwak has no potential conflicts of interest to disclose.

Franco Laghi reports grants from the National Science Foundation (USA), Veterans Admiration Research Services (USA), National Institutes of Health (USA). He has received support for educational events and speaker fees from Collage S.p.A (Italy) and SIP (Italian Society of Pulmonology).

Pierantonio Laveneziana reports personal fees (honoraria for lectures/presentations/speakers bureaus, participation on advisory board) and support for attending meetings and/or travel from Chiesi France.

Pyng Lee has no potential conflicts of interest to disclose.

William Man’s organisation has received funds to reimburse for his time for speaking as a non-promotional primary care educational event from Pfizer.

Hisako Matsumoto has received grants or support to Kindai University from Kyorin Pharmaceutical Co., Boehringer Ingelheim and Teijin Pharma, and lecture fees from AstraZeneca, Sanofi, Novartis Japan, GSK, Kyorin Pharmaceutical Co. and Boehringer Ingelheim.

Stuart B. Mazzone has received grants and personal fees from Merck Sharp and Dohme, Proctor and Gamble and GSK.

Walter T. McNicholas has no potential conflicts of interest to disclose.

Philip Molyneaux has no potential conflicts of interest to disclose.

David Montani reports lecture and advisory committee fees from Merck MSD, Boehringer and Ferrer, lecture fees from Chiesi, GSK, CSL Behring and Janssen, and travel support from Merck MSD, Janssen and Boehringer.

Alyn H. Morice has received consulting fees from Bayer, Bellus, Boehringer Ingelheim, Merck, Pfizer, Proctor & Gamble and Shionogi; lecture fees from Boehringer Ingelheim, Merck and AstraZeneca; and grant support from Proctor & Gamble, Merck, Afferent, Infirst, NeRRi and Nocion.

Manali Mukherjee has no potential conflicts of interest to disclose.

J. Alberto Neder has received honoraria for lectures from and has participated on advisory boards for AstraZeneca Canada.

Brian Oliver has received grants and/or personal fees from AstraZeneca, and Airway Vista 2018 South Korea.

Stylianos Orfanos has no potential conflicts of interest to disclose.

Devin Phillips reports a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada.

Paul Martin Putorahas no potential conflicts of interest to disclose.

Winfried Randerath has received travel grants and speaker’s fees from Inspire, Resmed, Philips Respironics, Weinmann, Heinen & Löwenstein, Boehringer Ingelheim, Novartis
Pharma, Genzyme and Berlin Chemie.

Peter Riddell has no potential conflicts of interest to disclose.

Imran Satia is currently supported by the ERS Respire 3 Marie Curie Fellowship, and reports grants from the North West Lung Centre Charity (UK) and the British Medical Association, consultancy fees from Merck MSD, and personal fees for educational talks from Astrazeneca, GSK.

Michele Schaeffer has no potential conflicts of interest to disclose.

Ueki Shigeharu has received grants to his institution from AstraZeneca, Novartis, Maruho Co. Ltd, the Japan Agency for Medical Research, the JSPS and VIB; consulting fees from GlaxoSmithKline; and payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing or educational events from AstraZeneca and GlaxoSmithKline; and is a member of the International Eosinophil Society.

Davina Simoes has no potential conflicts of interest to disclose.

Atsushi Suzuki reports lecture fees from Boehringer Ingelheim and GSK.

Giovanni Sotgiu has no potential conflicts of interest to disclose.

Sarah Svenningsen has no potential conflicts of interest to disclose.

Hui-leng Tan has no potential conflicts of interest to disclose.

Lowie Vanfleteren reports grants from Philips, personal fees from Pulmonx, grants and personal fees from AstraZeneca, personal fees from Chiesi, personal fees from GSK, personal fees from Novartis, personal fees from Menarini, grants from Fisher and Paykel, grants from Longfonds.

Johan Verbraecken has received speaker’s fees from AstraZeneca, Philips, Sanofi, Agfa-Gevaert, Springer and Somnomed, served on advisory boards for ResMed, Bioprojet and MSD, has receivied grants and personal fees from ResMed, Bioprojet and Jazz Pharmaceutics, and grants from AirLiquide, Westfalen Medical, SomnoMed, Vivisol, Total Care, Medidis, Fisher & Paykel, Wave Medical, OSG, Mediq Tefa, NightBalance, Heinen & Löwenstein, AstraZeneca, Accuramed, Bekaert Deslee Academy and UCB Pharma.

Victoria Villena Garrido has received honoraria for educational courses from Menarini.

Ioannis Vogiatzis has no potential conflicts of interest to disclose.

Joao Winck has no potential conflicts of interest to disclose.

Zaid Zoumot has been an investigator in trials of endobronchial valves for PulmonX and Spiration, coils for PnuemRx, thermal ablation for Uptake Medical Inc., and the airway bypass procedure for Broncus, and his previous institutions were reimbursed for trial expenses by the device manufacturers. He has received travel grants from PneumRx to attend international conferences and present research data.

Early Career Editors

Steven Cass has no potential conflicts of interest to disclose.

Mateusz Jankowski has no potential conflicts of interest to disclose.

Theodoros Kapellos has no potential conflicts of interest to disclose.

Heidi Makrinioti has no potential conflicts of interest to disclose.

Ana Oliveira has no potential conflicts of interest to disclose.

Managing Editor

Jonathan Hansen: jonathan.hansen@ersnet.org

This page was updated on 24 June 2024